Garden City, NY, United States of America

Nadim Shohdy

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Nadim Shohdy in Therapeutic Agents

Introduction

Nadim Shohdy is an accomplished inventor based in Garden City, NY (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of therapeutic agents. With a total of two patents to his name, his work focuses on innovative compounds that target specific diseases.

Latest Patents

Nadim Shohdy's latest patents include "Fused bicyclic heterocycles as therapeutic agents." This patent relates to compounds and pharmaceutical compositions that are used for treating diseases associated with nicotinamide phosphoribosyltransferase (NAMPT) expression. The disclosure emphasizes methods of inhibiting NAMPT with these compounds and treating related diseases. Another notable patent is "Inhibitors of GLI1 as therapeutic agents." This invention pertains to compounds and pharmaceutical compositions aimed at treating diseases linked to glioma-associated oncogene (Gli) expression. It outlines methods for inhibiting Gli expression and treating associated conditions.

Career Highlights

Nadim Shohdy is affiliated with New York University, where he continues to advance his research in therapeutic agents. His work has garnered attention for its potential impact on treating various diseases.

Collaborations

Some of his notable coworkers include Xinyan Huang and William J Greenlee, who contribute to the collaborative efforts in his research endeavors.

Conclusion

Nadim Shohdy's innovative work in developing therapeutic agents showcases his commitment to advancing medical science. His patents reflect a deep understanding of complex biological processes and the potential for new treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…